Tetra Bio Pharma Inc (TBPMQ)

[AJ Freely]

TBPMF - 2 FDA Phase II trial for CBD/THC inhalated instant pain relief for cancer against moriphine. Both started late mid April this year

Reborn1(10 weeks) - Qixleef (botanical version) & Calmz (syntehteic version); head-to-head test. A timed onset of relief from initial ingestion

REBORN1 is a 10-week open-label randomized study to evaluate the effect of inhaled QIXLEEF compared to morphine sulfate immediate release (MSIR) to improve fast onset of pain relief of breakthrough cancer pain
April 23: Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial

Plenitude© is a 4-week double-blind, randomized, placebo-controlled, parallel group design trial to evaluate the safety and efficacy of inhaled QIXLEEF™ to relieve uncontrolled cancer related pain in 78 adult patients with advanced incurable disease.
Sept 2020: Tetra Bio-Pharma Announces Plenitude Clinical Trial is Initiated

When these show proof of concept ...this will easily be a 100x stock. And the opioid crisis will have a fighting chance.